Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Bright
NCT04151940Recruiting
- Sponsor
- University of Washington
- Start
- Sep 2019
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial in non-small cell lung cancer (NSCLC), sponsored by University of Washington. Primary endpoint: Actuarial disease progression rate at 1 year. Started Sep 2019; status: recruiting.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04151940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04151940.